Journal for ImmunoTherapy of Cancer Issues Research Articles in February 2023 Edition
March 02, 2023
March 02, 2023
MILWAUKEE, Wisconsin, March 2 -- The Journal for ImmunoTherapy of Cancer, a peer-reviewed journal from the Society for Immunotherapy of Cancer that says it features all aspects of tumor immunology and cancer immunotherapy, posted research articles on the following topics in its February 2023 edition:
Basic tumor immunology:
* Venetoclax improves CD20 immunotherapy in a mouse model of MYC/BCL2 double-expressor diffuse large B-cell lymphoma.
* Downregulation . . .
Basic tumor immunology:
* Venetoclax improves CD20 immunotherapy in a mouse model of MYC/BCL2 double-expressor diffuse large B-cell lymphoma.
* Downregulation . . .